{"entity":{"type":"insider","cik":"0001709417","url":"/insider/0001709417","json_url":"/insider/0001709417.json","name":"Laliberte Kevin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2017-07-07","last":"2019-10-02","span_basis":"filed_date"},"name_variants":[{"name":"Laliberte Kevin","source":"filing","n_filings":5,"first_seen":"2017-07-07","last_seen":"2019-10-02"}],"transactions":[{"id":8768591,"accession":"0001562180-19-005055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-005055","line_url":"/filing/0001562180-19-005055","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001709417","owner_name":"Laliberte Kevin","owner_display_name":"Laliberte Kevin","owner_url":"/insider/0001709417","role":"Officer (Sr. VP, Product Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3696.0,"shares_display":"3,696","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":103488.0,"total_display":"103,488.00","total_whole":"103,488","shares_owned_after":5357.0,"shares_owned_after_display":"5,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-30","filed_date":"2019-10-02","scope":"insider","n_lines":2},{"id":8137918,"accession":"0001562180-19-004967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-004967","line_url":"/filing/0001562180-19-004967#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001709417","owner_name":"Laliberte Kevin","owner_display_name":"Laliberte Kevin","owner_url":"/insider/0001709417","role":"Officer (Sr. VP, Product Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":62000.0,"total_display":"62,000.00","total_whole":"62,000","shares_owned_after":8457.0,"shares_owned_after_display":"8,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-25","filed_date":"2019-09-27","scope":"insider"},{"id":8619003,"accession":"0001209191-19-044032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-044032","line_url":"/filing/0001209191-19-044032#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001709417","owner_name":"Laliberte Kevin","owner_display_name":"Laliberte Kevin","owner_url":"/insider/0001709417","role":"Officer (Sr. VP, Product Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1389.0,"shares_display":"1,389","price_per_share":15.97,"price_display":"15.97","price_state":"stated","total_value":22182.33,"total_display":"22,182.33","total_whole":"22,182","shares_owned_after":11557.0,"shares_owned_after_display":"11,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-31","filed_date":"2019-08-01","scope":"insider"},{"id":7871797,"accession":"0001209191-19-040371","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-040371","line_url":"/filing/0001209191-19-040371#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001709417","owner_name":"Laliberte Kevin","owner_display_name":"Laliberte Kevin","owner_url":"/insider/0001709417","role":"Officer (Sr. VP, Product Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1191.0,"shares_display":"1,191","price_per_share":14.17,"price_display":"14.17","price_state":"stated","total_value":16876.47,"total_display":"16,876.47","total_whole":"16,876","shares_owned_after":12946.0,"shares_owned_after_display":"12,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-02","scope":"insider"},{"id":5070417,"accession":"0001209191-17-044264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-044264","line_url":"/filing/0001209191-17-044264#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals, Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001709417","owner_name":"Laliberte Kevin","owner_display_name":"Laliberte Kevin","owner_url":"/insider/0001709417","role":"Officer (Sr. VP, Product Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Product Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6200.0,"shares_display":"6,200","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":105400.0,"total_display":"105,400.00","total_whole":"105,400","shares_owned_after":6200.0,"shares_owned_after_display":"6,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001685071","name":"Dova Pharmaceuticals Inc.","url":"/issuer/0001685071","role":"Officer (Sr. VP, Product Development)","n_filings":5,"first_seen":"2017-07-07","last_seen":"2019-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001709417","retrieved_at":"2026-08-26T07:23:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}